Legend Biotech (LEGN) Equity Ratio (2019 - 2025)
Legend Biotech (LEGN) posted Equity Ratio of 0.63 for Q1 2025, up 1.11% on a QoQ basis from 0.62 in Q4 2024, and down 3.94% year-over-year from 0.66 in Q1 2024.
Legend Biotech (LEGN) has 7 years of Equity Ratio data on file, last reported at 0.63 in Q1 2025.
- In Q1 2025, Equity Ratio fell 3.94% year-over-year to 0.63; the TTM figure through Mar 2025 stood at 0.63 (down 3.94% YoY), while the FY2024 annual figure was 0.62, down 7.97% from the prior year.
- Equity Ratio grew to 0.63 in Q1 2025, from 0.62 in the prior quarter.
- Across five years, Equity Ratio topped out at 0.73 in Q2 2023 and bottomed at 0.0 in Q1 2021.
- A 5-year average of 0.54 and a median of 0.64 in 2024 frame the typical range for Equity Ratio.
- Annual changes were most pronounced in 2022 — Equity Ratio jumped 211531788.55% — and 2023, when it retreated 23.91%.
- Year by year, Equity Ratio stood at 0.68 in 2021, then fell by 18.27% to 0.56 in 2022, then gained by 21.05% to 0.68 in 2023, then dropped by 7.97% to 0.62 in 2024, then advanced by 1.11% to 0.63 in 2025.
- The last three Equity Ratio figures came in at 0.63 (Q1 2025), 0.62 (Q4 2024), and 0.64 (Q3 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 0.04 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 0.42 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 0.73 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 0.77 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 0.21 |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | 0.67 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 0.63 |
| Dec 31, 2024 | 0.62 |
| Sep 30, 2024 | 0.64 |
| Jun 30, 2024 | 0.64 |
| Mar 31, 2024 | 0.66 |
| Dec 31, 2023 | 0.68 |
| Sep 30, 2023 | 0.73 |
| Jun 30, 2023 | 0.73 |
| Mar 31, 2023 | 0.54 |
| Dec 31, 2022 | 0.56 |
| Mar 31, 2022 | 0.71 |
| Dec 31, 2021 | 0.68 |
| Sep 30, 2021 | 0.28 |
| Jun 30, 2021 | 0.00 |
| Mar 31, 2021 | 0.00 |
| Dec 31, 2020 | 0.83 |
| Sep 30, 2020 | 0.00 |
| Jun 30, 2020 | 0.00 |
| Dec 31, 2019 | 0.53 |